VALENCIA, Calif., Aug. 25, 2016 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD)
(TASE:MNKD) announced that the United States District Court for the Central District of California has dismissed the class action
that was pending against MannKind Corporation and two of its executives. The Court granted the defendants’ motion to dismiss
the plaintiffs’ amended class action complaint without leave to amend, thereby closing the case. The plaintiffs can appeal
the decision within 30 days.
ABOUT MANNKIND CORPORATION
MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) focuses on the discovery and development of therapeutic products for patients with
diseases such as diabetes. MannKind maintains a website at www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well
as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent
automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain
other information to the website.
Company Contact: Rose Alinaya SVP, Finance 661-775-5300 ralinaya@mannkindcorp.com
